1. The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction
   Chandra Choudhury et al, 2024, Pharmacological Reviews CrossRef
2. Population variability of rhesus macaque (Macaca mulatta) NAT1 gene for arylamine N-acetyltransferase 1: Functional effects and comparison with human
   Sotiria Boukouvala et al, 2019, Scientific Reports CrossRef
3. Elucidation of dibenzo[a,l]pyrene and its metabolites as a mammary carcinogen: A comprehensive review
   Mohd Umar Azeem et al, 2021, NeuroPharmac Journal CrossRef
4. Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
   Raúl A. Salazar-González et al, 2022, Frontiers in Pharmacology CrossRef
5. HDAC3–ERα Selectively Regulates TNF-α-Induced Apoptotic Cell Death in MCF-7 Human Breast Cancer Cells via the p53 Signaling Pathway
   Seung-Ho Park et al, 2020, Cells CrossRef
6. Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2
   Samantha M. Carlisle et al, 2022, Frontiers in Pharmacology CrossRef
7. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells
   Kyung U. Hong et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef